← Back to Clinical Trials
Recruiting NCT07554612

NCT07554612 The Impact of Trunk and Lower Extremity Electrical Stimulation on Pelvic Floor Muscle Strength in Females

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07554612
Status Recruiting
Phase
Sponsor Okan University
Condition Healthy Women
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2026-03-23
Primary Completion 2026-05-22

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Electrical Muscle StimulationStandardized Exercise Protocol

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2026-03-23 with a primary completion date of 2026-05-22.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to investigate the effects of whole-body electrical muscle stimulation (EMS) applied to the trunk and lower extremity muscles on pelvic floor muscle strength in healthy women. Since pelvic floor muscles are deep-seated and can be difficult to activate voluntarily, this research explores whether stimulating related muscle groups (core and legs) can provide an indirect benefit to pelvic floor strength. Participants will be divided into three groups (EMS + exercise, Sham-EMS + exercise, and exercise only) and will undergo a 6-week intervention program. Changes in pelvic floor muscle strength will be evaluated using a perineometer to determine the effectiveness of this non-invasive approach.

Eligibility Criteria

Inclusion Criteria: * Biological female volunteers aged between 18 and 45 years. * Having a Body Mass Index (BMI) between 18.5 and 29.9 kg/m². * Being sedentary or having a low level of physical activity (not participating in regular exercise programs in the last 6 months). * Volunteering to participate in the study and signing the informed consent form. * Being mentally and physically capable of following the 12-week exercise and EMS protocol. Exclusion Criteria: * Having a history of pelvic floor surgery or major abdominal surgery. * Being pregnant or having given birth within the last 6 months. * Having a diagnosed neurological disorder that affects muscle control (e.g., Multiple Sclerosis, Parkinson's). * Having an active urinary tract infection or symptomatic pelvic organ prolapse. * Having a cardiac pacemaker or any metal implants in the trunk and hip area (contraindications for EMS). * Having chronic diseases that may interfere with exercise participation (e.g., uncontrolled hypertension, severe cardiovascular disease). * Having skin lesions, infections, or severe sensitivity in the areas where EMS electrodes will be applied. * Using medications that affect muscle metabolism or the neuromuscular system.

Contact & Investigator

Central Contact

Dilara Taskiran, PT

✉ dilarataskrannnn@gmail.com

📞 905308922902

Principal Investigator

Ahmet C AKGÖL, PhD, PT

STUDY CHAIR

Okan University

Frequently Asked Questions

Who can join the NCT07554612 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Healthy Women. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07554612 currently recruiting?

Yes, NCT07554612 is actively recruiting participants. Contact the research team at dilarataskrannnn@gmail.com for enrollment information.

Where is the NCT07554612 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07554612 clinical trial?

NCT07554612 is sponsored by Okan University. The principal investigator is Ahmet C AKGÖL, PhD, PT at Okan University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology